Segal Institute for Clinical Research Physician, Steven E. Chavoustie, MD, FACOG, CCRP Co-authors Titan Pharmaceuticals (TTP) Buprenorphine Implant Abstract  
12/20/2012 9:33:50 AM

MIAMI--(BUSINESS WIRE)--Segal Institute for Clinical Research, a consortium of psychiatric, addiction, medical and women’s health research sites, proudly congratulates Dr. Steven Chavousite for his co-authorship of the Titan Pharmaceuticals poster abstract, “Buprenorphine Implants for the Treatment of Opioid Dependence: Six and 12 Month Outcomes.”